[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@BiopharmIQ Avatar @BiopharmIQ BiopharmIQ by Amp

Several biotech companies are expecting significant catalysts in Q3 2025, including phase X and phase X readouts for various assets. Notable companies with upcoming readouts include $ARCT, $IONS, and $FBIO, with potential FDA approvals and data releases that could impact their stock performance. Additionally, there have been recent M&A deals, such as Sanofi acquiring UK-based vaccine startup ViroBio, and Merck acquiring Verona Pharma for $10B.

Engagements: XXXXXX #

Engagements Line Chart

Mentions: XX #

Mentions Line Chart

Followers: XXXXXX #

Followers Line Chart

CreatorRank: XXXXXXX #

CreatorRank Line Chart

Social Influence #

Social category influence stocks XXXX% finance XXXX% cryptocurrencies XXXX% countries XXXX% technology brands XXX%

Social topic influence $dmac #4, $anab #1, $crdf #1, $arct #1, $asnd #1, $srpt #10, $repl #1, $nams #1, $lrmr #1, $mltx #1

Top accounts mentioned or mentioned by @beachdudeca @domvacchiano @ascp @bowtiedbiotech @marketwirenews @biostocks @aahs @aacr @aan23 @cmsc @isth @asco @ohadhammer @boudin420 @ian_gravelle @era @endo @eccmid @seed @ats

Top assets mentioned ArbitrageCT (ARCT) Sarepta Therapeutics, Inc. (SRPT) MoonLake Immunotherapeutics Class A Ordinary Shares (MLTX) Eli Lilly and Company (LLY) Gilead Sciences, Inc. (GILD) Arcellx, Inc. Common Stock (ACLX) Apellis Pharmaceuticals, Inc. Common Stock (APLS) Hundred Million (100M) ATAI Life Sciences (ATAI) Recursion Pharmaceuticals, Inc. Class A Common Stock (RXRX) Jazz Pharmaceuticals, Inc. (JAZZ) Crinetics Pharmaceuticals, Inc. (CRNX) Rhythm Pharmaceuticals, Inc. Common Stock (RYTM) Edgewise Therapeutics, Inc. Common Stock (EWTX) Madrigal Pharmaceuticals, Inc. Common Stock (MDGL) Alkermes Inc. plc (ALKS) Taraxa (TARA) Vir Biotechnology, Inc. Common Stock (VIR) BridgeBio Pharma, Inc. Common Stock (BBIO) Incyte Corporation (INCY) Summit Therapeutics Inc. Common Stock (SMMT) Avidity Biosciences, Inc. Common Stock (RNA) GSK plc (GSK) Regeneron Pharmaceuticals Inc (REGN) PTC Therapeutics, Inc. (PTCT) Roivant Sciences Ltd. Common Shares (ROIV) Biohaven Pharmaceutical Holding Company Ltd. (BHVN) SpringWorks Therapeutics, Inc. Common Stock (SWTX) Arvinas, Inc (ARVN) SuperRare (RARE)

Top Social Posts #

Top posts by engagements in the last XX hours

"Biotech Stock Catalyst Watchlist 🚀 🎯 Ph2 & Ph3 readouts in Q2/H1 2025. $DMAC Phase X $ACRS Phase 2a $ARCT Phase X $INMB Phase X $KPTI Phase X $TARA Phase X $ROIV Phase X $EGRX Phase 2/3 $VIR Phase X $APLM Phase X $LLY Phase 2b $ANAB Phase X $BHVN Phase X $RXRX Phase X $VIRX Phase X $VIRX Phase X $SWTX Phase X $KZIA Phase X $SLS Phase 2a $AGEN Phase X $ACRS Phase X $CRDF Phase X $VRCA Phase X $NKTR Phase X $KAPA Phase X $CYBN Phase X $PROK Phase X $SPRO Phase X $CRDL Phase X $ATAI Phase X $INMB Phase X $ACIU Phase X $IMRX Phase 2a Check out the image for more details 📸"
@BiopharmIQ Avatar @BiopharmIQ on X 2025-06-29 18:40:13 UTC 25.9K followers, 33.2K engagements

"Biotech Stock Catalyst Watchlist 🚀 🎯 Ph2 & Ph3 readouts in Q2 2025 (2/2). $SLS Phase 2a $LLY Phase 2b $ROIV Phase X $APLM Phase X $ANAB Phase X $BHVN Phase X $MLYS Phase X $ARCT Phase X $PROK Phase X $ANRO Phase X $ASND Phase X $MURA Phase X $INMB Phase X $CRDL Phase X $INMB Phase X $ACIU Phase X $GRI Phase 2a $VTYX Phase 2a $IMRX Phase 2a $IMRX Phase 2a $ALT Phase 2b $SPRO Phase X $PYPD Phase X $ATAI Phase X Check out the image for more details 📸"
@BiopharmIQ Avatar @BiopharmIQ on X 2025-06-08 18:09:55 UTC 25.9K followers, 1607 engagements

"Biotech Stock Catalyst Watchlist 🚀 🎯 Ph2 & Ph3 readouts in Q2 2025 (1/2). $RVPH Phase X $VTGN Phase X $LLY Phase X $AGEN Phase X $GILD Phase X $IFRX Phase X $ALLO Phase X $HCM Phase X $PDSB Phase X $LLY Phase X $HCM Phase X $BCYC Phase 2/3 $PDSB Phase X $JAZZ Phase X $JAZZ Phase X $AAPG Phase X $CADL Phase X $KPTI Phase X $ACLX Phase X $DMAC Phase X $ACRS Phase 2a $CMPS Phase X $NKTR Phase 2b $KPTI Phase X $EWTX Phase X $EWTX Phase X $TARA Phase X $ROIV Phase X $XOMA Phase X $EGRX Phase 2/3 $VIR Phase X $APLM Phase X $PRAX Phase 2b $LLY Phase 2b $ANAB Phase X $BHVN Phase X $RXRX Phase 2"
@BiopharmIQ Avatar @BiopharmIQ on X 2025-05-25 18:29:16 UTC 25.9K followers, 31.7K engagements

"Let's see how many of the XX biopharma-focused hedge funds hold these tickers (5 is 🔥). $PRAX 6/34 🔥 $CRDF 2/34 Access our FREE hedge fund screener & search your fav tickers 👇"
@BiopharmIQ Avatar @BiopharmIQ on X 2025-07-27 17:48:06 UTC 25.9K followers, 1903 engagements

"📢 M&A News: Sanofi to acquire UK-based Vaccine Startup Vicebio 💸 $1.15B upfront + up to $450M in milestones. 🧪 Adds early-stage RSV + hMPV combo vaccine candidate (VXB-241) and 'Molecular Clamp' tech to pipeline. ❄ Molecular Clamp enables fully liquid fridge-stable vaccinesboosting efficiency distribution and prefilled syringe use. 📅 Deal expected to close in Q4 2025 See image for more details 👇"
@BiopharmIQ Avatar @BiopharmIQ on X 2025-07-22 14:39:04 UTC 25.8K followers, 3585 engagements

"📌 Biotech Stock News 6/6 @ Open 🔔 $RXRX XX% Boltz-2: MIT and $RXRX Partnership $ARVN X% Vepdegestrant submitted NDA $XLO X% $50M public offering closed $AYTU X% $14.4M upsized stock offering $ATXS X% Allergy data @ AACI'25 $NRIX X% Bexobrutideg Ph1 data @ EHA'25 $ARQT X% ZORYVE long-term data shared $APLS X% EMPAVELI shows 1-year efficacy $ADXN X% GABAB PAM reduces cough $TRVI X% $115M offering completed $OSTX X% OST-HER2 submitted RMAT request $VALN -X% IXCHIQ shows antibody persistence $GLYC -X% Merger with Crescent approved $MAIA -X% New responder in Ph2 trial See the image and comments"
@BiopharmIQ Avatar @BiopharmIQ on X 2025-06-06 16:15:38 UTC 25.9K followers, 5772 engagements

"Each quarter we identify major catalyst events 🥳 Likely to move the stock +/- by XX% 📈 📉 $PRAX Ulixacaltamide (PRAX-944) $CRDF Onvansertib + SoC Access our FREE Big Mover Report 👇"
@BiopharmIQ Avatar @BiopharmIQ on X 2025-07-27 17:48:05 UTC 25.9K followers, 2034 engagements

"$ASND ✅ FDA approves SKYTROFA (lonapegsomatropin-tcgd) 👀 👇"
@BiopharmIQ Avatar @BiopharmIQ on X 2025-07-28 15:59:47 UTC 25.9K followers, 1287 engagements

"The story behind @BiopharmIQ - your favorite biotech data provider ( we hope🤞)"
@BiopharmIQ Avatar @BiopharmIQ on X 2025-07-26 22:56:32 UTC 25.9K followers, 4171 engagements

"📌 Biotech Stock News 7/11 @ Open $CVM XX% Partnership for Multikine in Cancer $DARE X% Receives $6M Grant for Drug Delivery $MIRA X% SKNY-1 Results Update $NKGN X% 1st Dose of Troculeucel Administered $BBIO X% Business Combination Update $IKNA -X% ISS and Glass Lewis Recommend Merger $VALN -X% IXCHIQ EMA Restriction Lifted $CAPR -XX% Deramiocel BLA Regulatory Update $MIST -XX% Pricing of $52.5M & CRL Acceptance See the image and comments for more details 📸👇"
@BiopharmIQ Avatar @BiopharmIQ on X 2025-07-11 16:53:24 UTC 25.9K followers, 4621 engagements

"🤔 How many of the XX biopharma hedge funds have positions in any of the tickers mentioned above Based on Q1 XX HF data 📊 $ABVX 8/34 $AXSM $BBIO $CELC $CRDF $CRNX 7/34 $SRPT 6/34 $VKTX 5/34 Access our FREE screener to check your fave stocks 👇"
@BiopharmIQ Avatar @BiopharmIQ on X 2025-07-26 16:36:46 UTC 25.9K followers, 2897 engagements

"🔔 Opaleye Management Q1 25* Holdings Released. 🐳 Holdings: XX Holdings in Top 20: XXXXX% Qtr over Qtr Change**: -XXXXX% 🚀 Top Holdings: $HROW $ETON $SNWV $LQDA $RYTM $CDXS $IMNM $TGTX $ARVN $OCUL $EWTX $TARA $DNA $GOSS $ANIK $PTGX $XOMA $TRVI $PVLA $GOSS *Holdings as of 3/31/25 in SEC form 13F **Change in value of public company shares held See image for more details 📸👇"
@BiopharmIQ Avatar @BiopharmIQ on X 2025-05-15 22:19:00 UTC 25.9K followers, 13.2K engagements

"📌 Biotech Stock News 6/13 @ Open $URGN XX% FDA Approves ZUSDURI (mitomycin) $ELVN XX% ELVN-001 Data @ EHA'25 $TLSA XX% Foralumab Ph2 Expansion $CNTB X% Rademikibart Data @ EAACI'25 $CLDX X% Barzolvolimab Data @ EAACI'25 $ATXS X% ALPHA-SOLAR Trial Data @ EAACI'25 $GLPG X% ATALANTA-1 Data @ EHA'25 $JNJ X% JNJ-90014496 Data @ EHA'25 $IPHA X% IPH6501 Preclinical Data @ EHA'25 $MRK X% KEYTRUDA (pembrolizumab) FDA Approval $BPMC X% AYVAKIT/AYVAKYT LT Data @ EHA'25 $BCRX X% ORLADEYO Approved in Colombia $BEAM -X% BEAM-101 Data @ EHA'25 $INCY -X% Retifanlimab Publication & New Partnerships $GUTS -1%"
@BiopharmIQ Avatar @BiopharmIQ on X 2025-06-13 16:16:50 UTC 25.8K followers, 4094 engagements

"🔔 RA Capital Q1 25* Holdings Released. 🐳 Holdings: XX Holdings in Top 20: XXXXX% Qtr over Qtr Change**: -XXXXX% 🚀 Top Holdings: $ASND $PCVX $RYTM $JANX $NAMS $ACLX $EWTX $RNA $WVE $ETNB $SPRY $SION $LENZ $DYN $TYRA $MLYS $GERN $RXST $BCAX $IRON *Holdings as of 3/31/25 in SEC form 13F **Change in value of public company shares held See image for more details 📸 👇"
@BiopharmIQ Avatar @BiopharmIQ on X 2025-05-15 21:31:42 UTC 25.9K followers, 17.8K engagements

"🧬 Biotech Weekly News 04/21/25 - 04/25/25 Major Movers 📈 📉 $RZLT XX% Positive Recommendation Ph3 sunRIZE Study $SMMT XX% Ivonescimab Shows Superiority in NSCLC $HCM XX% Completed Enrollment Ph2 Registrational Study $TLSA XX% Initiated Dosing Ph2 Intranasal Foralumab Trial $BCAX XX% Updated Data from Phase 1/1b Trial $COEP -XX% Announced Merger Agreement $INTS -XX% $2.35M Public Offering $VYNE -XX% Update on VYN202 Program $IBIO -XX% Licensing of Antibody from AstralBio $BCTX -XX% Pricing of $13.8M Offering $4.50/share See image below. 📸 👇"
@BiopharmIQ Avatar @BiopharmIQ on X 2025-04-25 22:36:18 UTC 25.8K followers, 6417 engagements

"📡 July Biotech PDUFA Pulse: Whats on the FDA Radar 🔍 $REGN: Lynozyfic - Approved ✅ $RHHBY: Columvi + GemOx $REPL: RP1 + Opdivo (nivolumab) $GSK: Blenrep combinations (BVd & BPd) $ASND: TransCon hGH $APLS: EMPAVELI (pegcetacoplan) $PTCT: Sephience (sepiapterin) $REGN: Odronextamab $KALV: Sebetralstat - Approved ✅ Check out the July PDUFA calendar. 📅👇"
@BiopharmIQ Avatar @BiopharmIQ on X 2025-07-07 19:49:29 UTC 25.9K followers, 40.2K engagements

"Biotech Stock Catalyst Watchlist 🚀 🎯 Ph2 & Ph3 readouts in Q2 2025 (1/2). $GILD Phase X $ALLO Phase X $HCM Phase X $PDSB Phase X $LLY Phase X $HCM Phase X $BCYC Phase 2/3 $PDSB Phase X $JAZZ Phase X $JAZZ Phase X $AAPG Phase X $IMNN Phase X $CADL Phase X $ANAB Phase 2b $ALKS Phase X $PCRX Phase X $KPTI Phase X $ACLX Phase X $OSTX Phase X $DMAC Phase X $ACRS Phase 2a $SRRK Phase X $CMPS Phase X $NKTR Phase 2b $KPTI Phase X $EWTX Phase X $EWTX Phase X $TARA Phase X $ROIV Phase X $EGRX Phase 2/3 $VIR Phase X $APLM Phase X $LLY Phase 2b $ANAB Phase X $BHVN Phase X $RXRX Phase X $VIRX Phase 2"
@BiopharmIQ Avatar @BiopharmIQ on X 2025-06-01 18:49:49 UTC 25.9K followers, 26.2K engagements

"📌 Biotech Stock News 7/28 @ Open 🔔 $CELC XXX% Topline Data from Ph3 VIKTORIA-1 Trial $ENTX XX% FDA Agreement on Primary Endpoint for Ph3 EB613 Trial $SRPT X% Clarifying Statement on ELEVIDYS $ENLV X% Target Date for Ph2 Data $STXS X% FDA Clearance for MAGiC Sweep Catheter $MAIA X% Fast Track Designation for Ateganosine $LENZ X% NMPA Submission for LNZ100 in China $ARWR X% Earns $100M Milestone from Sarepta $APYX X% Renuvion Launch in China $ONC X% Positive CHMP Opinion for TEVIMBRA $URGN X% Ph3b Study Results Published $ZVRA X% EU Application for Arimoclomol $ZYME X% IND Clearance for ZW251"
@BiopharmIQ Avatar @BiopharmIQ on X 2025-07-28 15:59:46 UTC 25.9K followers, 2236 engagements

"📌 Biotech Stock News 07/03 @ Open🧬 📰 $LIXT XX% Closing of $5M Placement $THTX XX% Acquired by CB Biotechnology $CLRB X% Closing of $6.9M Offering $OSTX X% End of Phase X Meeting Granted $VRTX X% Present Longer-Term Data on CASGEVY at EHA $ELAN X% Global Licensing Agreement for NUZ-001 Commercialisation $OGEN -X% Completes $16.5M Offering $NVS -X% Update on Ph3 GCAptAIN Study $FDMT -X% Accelerated 4D-150 Ph3 Development $DYN -X% Closing of Public Offering $NKTR -X% Closing of $115M Offering $IMAB -X% Positive Givastomig Ph1b Data $BCAB -X% Data from BA3182 Dose Escalation $INO -XX% Pricing"
@BiopharmIQ Avatar @BiopharmIQ on X 2025-07-03 15:48:32 UTC 25.8K followers, 2996 engagements

"Check out our catalyst calendar 👇 & stay on top of key biopharma readouts 📅 🚀 $XBI $IBB #biotech"
@BiopharmIQ Avatar @BiopharmIQ on X 2025-07-25 22:34:12 UTC 25.9K followers, 1649 engagements

"Don't miss out on future PDUFAs & AdComs 🎯 🗓 PDUFA events: groundbreaking stock milestones ✨ often trigger major stock movements 📈 ideal for trading & options strategies 💸 Access our free PDUFA Report to see more info 👇"
@BiopharmIQ Avatar @BiopharmIQ on X 2025-07-07 19:49:29 UTC 25.9K followers, 9454 engagements

"Biotech Stock Catalyst Watchlist 🚀 🎯 Ph2 & Ph3 readouts in Q3 2025. $NAMS Phase 2a $CRDF Phase X $IXHL Phase X $ENTX Phase X $MLTX Phase X $LRMR Phase X $KAPA Phase X $RAPP Phase 2a $PMVP Phase X $ATAI Phase 2b $ARCT Phase X $CLNN Phase X $AMLX Phase X $PRAX Phase 2b $ANAB Phase X $BINV Phase 2a $VYNE Phase 2b $PCSA Phase X $LSTA Phase 2a $BINV Phase 2a $LLY Phase X $ATAI Phase 2b $GRI Phase 2a $FDMT Phase X $HRMY Phase X $IONS Phase X $ENTA Phase X $KALA Phase 2b $LTRN Phase X $INBX Phase X $BTAI Phase X $PRAX Phase X $ATYR Phase X $FBIO Phase X $UPB Phase X $INMB Phase X $IFRX Phase 2a"
@BiopharmIQ Avatar @BiopharmIQ on X 2025-07-20 20:51:42 UTC 25.9K followers, 36.4K engagements

"Biotech Stock Catalyst Watchlist 🚀 🎯 Ph2 & Ph3 readouts in Q2 2025 (1/2). $JAZZ Phase X $ALKS Phase X $PCRX Phase X $KPTI Phase X $ACLX Phase X $OSTX Phase X $DMAC Phase X $SRRK Phase X $ACRS Phase 2a $NKTR Phase 2b $CMPS Phase X $KPTI Phase X $EWTX Phase X $EWTX Phase X $TARA Phase X $VIR Phase X $RXRX Phase X $VIRX Phase X $VIRX Phase X $SWTX Phase X $KZIA Phase X $NUVL Phase X $AGEN Phase X $ACRS Phase X $CRDF Phase X $VRCA Phase X $NKTR Phase X $KAPA Phase X $CYBN Phase X $EGRX Phase 2/3 Check out the image for more details 📸"
@BiopharmIQ Avatar @BiopharmIQ on X 2025-06-08 18:09:54 UTC 25.9K followers, 35.8K engagements

"🧬 Biotech Weekly News 6/30/25 - 7/3/25 Major Movers 📈 📉 $THTX XX% To be Acquired by CB Biotechnology $NGNE XX% Registrational Trial Design for NGN-401 $ATAI XX% Topline Results Ph2b TRD Study $ACOG XX% Pre-Clinical Data for ALPHA-1062 $IGMS XX% To be Acquired by Concentra $OGEN -XX% Pricing of $20M Public Offering $INMB -XX% Key Findings from Ph2 Trial $INO -XX% Pricing of $25M Offering $CLRB -XX% Pricing of $6M Offering $UNCY -XX% CRL for Oxylanthanum Carbonate"
@BiopharmIQ Avatar @BiopharmIQ on X 2025-07-04 17:51:20 UTC 25.8K followers, 7420 engagements

"🧬 Weekly Biotech Moves 7/21/25 - 7/25/25 $XBI: XXXX% ($87.61) 🟢 $IBB: XXXX% ($135.50) 🟢 📸👇"
@BiopharmIQ Avatar @BiopharmIQ on X 2025-07-25 22:38:31 UTC 25.9K followers, 3734 engagements

"📣 Biotech Stock News 07/08 @ Open 🧬 📰 $PROK XXX% Topline Results for Phase X Trial $ZVSA XX% Supports FDA Emergency Use of VAR XXX $RLYB XX% Sells Interest in REV102 Program $PSTV XX% Initial Patients Treated in Dose Trial $HUMA XX% Symvess ECAT Approval from U.S. DLA $NBTX XX% Regulatory Harmonization and Patent Filed $RXRX XX% Acquires Full Rights to REV102 $LGVN X% FDA Approves IND for Pediatric DCM $ONCY X% Highlights Pelareorep Survival Data $LRMR X% Nonclinical Data on Nomlabofusp $RMTI X% Three-Year Partnership for Hemodialysis Supply $ETON X% FDA Accepts New Drug Application $CRGX"
@BiopharmIQ Avatar @BiopharmIQ on X 2025-07-08 15:06:21 UTC 25.9K followers, 4158 engagements

"🧬 Biopharma Weekly Recap 📝 Interesting posts/ppl to check out 👇 @BowTiedBiotech 1/ 🫁 Mercks $10B Verona Bet: A Biotech Thread @Andre_AGTC $VRNA aquisition has positive effect on bios which are potential BO candidates $MDGL $MIRM $BBIO $SRRK $CRNX @JacobPlieth $VRNAs Enfisentirine Composition Patent Expired in 2020 Not a Concern for $MRK @LifeSciVC $MRK will acquire Verona Pharma $VRNA for $10B. Fun bit of biotech history. @A_May_MD Parallels Between $NKTR and $VRNA: Early-Stage Setup Market Potential and Sentiment Dynamics @doepke_michel $MDGL Positioned as Potential Takeover Target"
@BiopharmIQ Avatar @BiopharmIQ on X 2025-07-12 18:32:23 UTC 25.9K followers, 14K engagements

"📌 Biotech Stock News 7/21@ Midday 🔔 $PMN XXX% Fast Track Designation for PMN310 $RDHL XX% Positive FDA Feedback on RHB-204 $AMIX XX% Granted U.S. Patent for Treatments $SABS XX% Oversubscribed $175M Private Placement $LGVN XX% Licensing New Cardiac Stem Cell Tech $CNTB XX% Terminate ADR Program and List Shares $DMAC XX% Raises $30M in Private Placement $NCNA X% Cancels Outstanding Series A Warrants $CGTX X% Proteomic Analysis on Zervimesine's Effects $CGEN X% First Patient Dosed in COM701 Trial $CERS X% Additional Defense Award for Hemorrhage Care $AUTL X% CAR-T Therapy Granted EU"
@BiopharmIQ Avatar @BiopharmIQ on X 2025-07-21 17:53:30 UTC 25.9K followers, 5283 engagements

"📌 Biotech Stock News 7/7 @ Open 🧬 📰 $COGT XX% Topline Results from SUMMIT Trial $KALV XX% FDA Approves First Oral Treatment for Hereditary Angioedema $FBIO X% Granted Orphan Drug Designation for CAR T-cells $COLL X% $150M Share Repurchase Program $LXEO X% Breakthrough Therapy Designation for LX2006 $ALUR X% Submission of PMA and Study Analyses $URGN X% Completion of Ph3 UTOPIA Trial $ALC X% Acquires LumiThera and Asset for Wet AMD Treatment $BSX X% FDA Approval for Expanded Labeling $NTRA -X% Data on Tissue-Free MRD Assay $DNLI -X% FDA Acceptance and Priority Review for BLA $NRIX -2%"
@BiopharmIQ Avatar @BiopharmIQ on X 2025-07-07 16:06:15 UTC 25.8K followers, 3459 engagements

"📢 M&A News: iTeos $ITOS Acquired by Concentra for $10.047/share + CVR🤝 💸 CVR includes XXX% of net cash $475M at closing + XX% of proceeds from asset sales within X months 📅 Deal expected to close Q3 2025 Check out our free biopharma M&A tracker 👇"
@BiopharmIQ Avatar @BiopharmIQ on X 2025-07-21 17:53:32 UTC 25.8K followers, 4575 engagements

"Biotech Stock Catalyst Watchlist 🚀 🎯 Ph2 & Ph3 readouts in Q3 2025. $CRDF Phase X $NAMS Phase 2a $IXHL Phase X $CRDL Phase X $ENTX Phase X $CGEM Phase X $MLTX Phase X $LRMR Phase X $KAPA Phase X $RAPP Phase 2a $PMVP Phase X $ATAI Phase 2b $ARCT Phase X $CLNN Phase X $AMLX Phase X $PRAX Phase 2b $ANAB Phase X $BINV Phase 2a $VYNE Phase 2b $PCSA Phase X $LSTA Phase 2a $BINV Phase 2a $INMB Phase X $LLY Phase X $ATAI Phase 2b $GRI Phase 2a $FDMT Phase X $HRMY Phase X $IONS Phase X $ENTA Phase X $KALA Phase 2b $LTRN Phase X $INBX Phase X $BTAI Phase X $PRAX Phase X $ATYR Phase X $FBIO Phase 2"
@BiopharmIQ Avatar @BiopharmIQ on X 2025-07-27 17:48:05 UTC 25.9K followers, 13K engagements

"📌 Biotech Stock News 07/23 @ Open $ABVX XXX% Positive Ph3 Results in Ulcerative Colitis $CLSD XX% Approval of Suprachoroidal Treatment in Canada $ARWR X% Statement on Ongoing Agreement Status $SLDB X% FDA Fast Track for Gene Therapy $PSTV X% $1.6M Advance Payment from CPRIT $LTRN X% Complete Response in Lymphoma Patient $IDYA X% Oral Presentation at IASLC 2025 $RNA X% Breakthrough Therapy Designation for DMD Treatment $ANIP X% Results from NEW DAY Clinical Trial $SNY X% XX% Reduction in RSV Visits $RHHBY X% Approval for Itovebi in breast cancer $PRCT X% WATER IV Trial Completion $VRTX 1%"
@BiopharmIQ Avatar @BiopharmIQ on X 2025-07-23 15:43:16 UTC 25.9K followers, 4513 engagements

"July PDUFA Approval Decision Calendar Approval decisions for: $REGN $RHHBY $REPL $ASND $APLS $PTCT $KALV See details in our PDUFA calendar 📅 👉"
@BiopharmIQ Avatar @BiopharmIQ on X 2025-06-30 14:37:16 UTC 25.9K followers, 29.2K engagements

"Biotech Stock Catalyst Watchlist 🚀 🎯 Ph2 & Ph3 readouts in Q3 2025. $PHVS Phase X $PHVS Phase X $NAMS Phase 2a $CGTX Phase X $DMAC Phase X $COGT Phase X $ENTX Phase X $MLTX Phase X $LRMR Phase X $RAPP Phase 2a $PMVP Phase X $ATAI Phase 2b $ARCT Phase X $CLNN Phase X $AMLX Phase X $PRAX Phase 2b $ANAB Phase X $BINV Phase 2a $VYNE Phase 2b $PCSA Phase X $LSTA Phase 2a $BINV Phase 2a $APGE Phase X $INMB Phase X $LLY Phase X $ATAI Phase 2b $GRI Phase 2a $FDMT Phase X $HRMY Phase X $IONS Phase X $ENTA Phase X $KALA Phase 2b $LTRN Phase X $INBX Phase X $BTAI Phase X $PRAX Phase X $ATYR Phase 3"
@BiopharmIQ Avatar @BiopharmIQ on X 2025-07-06 18:36:29 UTC 25.9K followers, 54.9K engagements

"🧬 Biotech Weekly News 7/14/25 - 7/18/25 Major Movers 📈 📉 $TELO XX% Telomir-1 Update in Prostate Cancer $KAPA XX% Positive Results from Ph2 Trial $MEIP XX% $100M Private Placement $DARE XX% Ovaprene Interim Ph3 Results $RCKT XX% Receives RMAT Designation for Gene Therapy $SRPT -XX% FDA Shipment Halt Warning for Elevidys $CLSD -XX% Explore Strategic Alternatives for SCS Platform $BCLI -XX% Nasdaq Delisting & OTCQB Transition $ABOS -XX% Strategic Collab. for Alzheimer's Therapy $IKNA -X% Stockholder Approval of Merger See image below. 📸 🚨 $SRPT closed down XX% after reports of 3rd gene"
@BiopharmIQ Avatar @BiopharmIQ on X 2025-07-18 22:53:55 UTC 25.8K followers, 7235 engagements

"🧬 Biopharma Weekly Recap 📝 Interesting posts/ppl to check out 👇 @A_May_MD $ABVX: High-Risk High-Reward Setup with Undervalued PoS @seedy19tron $ABVX Still Undervalued Post-Offering Strong Buyout Potential @semodough $ABVX Congrats to few #Biotech funds who owned $ABVX going into data @bio_clouseau $SRPT Platform Designation Granted Then Pulled Amid FDA Dispute @richtrades100 Clarifying the $SRPT Elevidys FDA Situation @Pharmdca $VKTX Earnings Call: No New Insights Data Likely in August @princetongb Lean Team Strong Results: VKTX as a Biopharma Outlier @TomSilver39 JPM: $VKTX 2Q25 Review:"
@BiopharmIQ Avatar @BiopharmIQ on X 2025-07-26 16:34:19 UTC 25.9K followers, 18.4K engagements

"📌 Biotech Stock News 05/21 @ Open 🧬 📰 $BLTE X% Tinlarebant Breakthrough Therapy Designation $SRPT X% Update on UK Dosing in ENVISION Study $TNXP X% First Patient Dosed in TNX-102 SL Ph2 Study $ORKA X% First Participants Dosed in ORKA-002 Ph1 Trial $EVFM X% Signs SOLOSEC License Agreement for Middle East $JNJ X% AdComm Votes on DARZALEX FASPRO $RHHBY X% Update on FDA AdCom Meeting $OPTN X% Paratek Completes Acquisition of Optinose $TEVA X% Upsizing and Pricing of Senior Notes $TELO X% Secures $3M for Rare Disease IND $SLNO -X% Data Presentation on VYKAT XR $NLSP -X% New Data on Mazindol ER"
@BiopharmIQ Avatar @BiopharmIQ on X 2025-05-21 15:54:41 UTC 25.9K followers, 2687 engagements

"🧬 Biotech Weekly News 7/21/25 - 7/25/25 Major Movers 📈 📉 $ABVX XXX% Positive Ph3 Results in Ulcerative Colitis $LYEL XX% Up to $100M Equity Placement $CNTB XX% Terminate ADR Program & List Shares $CRDL XX% Database Lock for Ph2 Trial $DMAC X% Raises $30M in Private Placement $REPL -XX% Complete Response Letter for RP1 $IMNN -XX% Reverse Stock Split $PHVS -XX% Pricing of $175M Offering $MEIP -XX% Closing of $100M Private Placement $ALKS -X% Topline Results from Ph2 Study See image below. 📸 🚨 Ahead of $ABVXs massive move on positive Ph3 UC data @A_May_MD laid out a deep"
@BiopharmIQ Avatar @BiopharmIQ on X 2025-07-25 22:34:11 UTC 25.9K followers, 9088 engagements

"📢 M&A News: Theratechnologies $THTX Acquired by CB Biotechnology for up to $254M 🤝 💵 $3.01/sh in cash + up to $1.19/sh CVR 📈 $THTX up XX% at open 🗓 Expected to close during the Companys Q4 ending November XX 2025. See more information 👇 📸"
@BiopharmIQ Avatar @BiopharmIQ on X 2025-07-03 14:42:08 UTC 25.8K followers, 10.8K engagements

"Biotech Stock Catalyst Watchlist 🚀 🎯 Ph2 & Ph3 readouts in Q3 2025. $NAMS Phase 2a $CGTX Phase X $CRDF Phase X $DMAC Phase X $IXHL Phase X $ENTX Phase X $MLTX Phase X $LRMR Phase X $RAPP Phase 2a $PMVP Phase X $ATAI Phase 2b $ARCT Phase X $CLNN Phase X $AMLX Phase X $PRAX Phase 2b $ANAB Phase X $BINV Phase 2a $VYNE Phase 2b $PCSA Phase X $LSTA Phase 2a $BINV Phase 2a $INMB Phase X $LLY Phase X $ATAI Phase 2b $GRI Phase 2a $FDMT Phase X $HRMY Phase X $IONS Phase X $ENTA Phase X $KALA Phase 2b $LTRN Phase X $INBX Phase X $BTAI Phase X $PRAX Phase X $ATYR Phase X $FBIO Phase X $UPB Phase 2"
@BiopharmIQ Avatar @BiopharmIQ on X 2025-07-13 18:07:52 UTC 25.9K followers, 36K engagements

"Each quarter we identify major catalyst events 🥳 Likely to move the stock +/- by XX% 📈 📉 $MLTX Sonelokimab $LRMR Nomlabofusp (CTI-1601) $IFRX INF904 Access our FREE Big Mover Report 👇"
@BiopharmIQ Avatar @BiopharmIQ on X 2025-07-20 20:51:43 UTC 25.9K followers, 1101 engagements

"🔔 Baker Bros. Q1 25* Holdings Released. 🐳 Holdings: XX Holdings in Top 20: XXXXX% Qtr over Qtr Change**: -XXXX% 🚀 Top Holdings: $ONC $INCY $ACAD $MDGL $SMMT $INSM $RYTM $RVMD $KYMR $ALKS $EWTX $REPL $INSM $IMVT $BCYC $IMCR $KNSA $ABCL $RARE $DNLI *Holdings as of 3/31/25 in SEC form 13F **Change in value of public company shares held See image for more details 📸👇"
@BiopharmIQ Avatar @BiopharmIQ on X 2025-05-15 22:05:13 UTC 25.9K followers, 21.2K engagements

"6 Stocks Likely to Move Big on Rare/Genetic Disease Readouts in Q3 XX 📈 📉 See 🧵 for more details about each asset/readout 👇 $ARCT (Mid-2025) ARCT-032 / Cystic Fibrosis / Phase X $IONS (August XX 2025) Donidalorsen / Hereditary angioedema / PDUFA $FBIO (September XX 2025) ✔ CUTX-101 (Copper Histidinate) / Menkes Disease / PDUFA $KALA (Q3 2025) KPI-012 / Persistent Corneal Epithelial Defect / Phase 2b $HRMY (Q3 2025) Zygel (ZYN002 CBD Gel) / Fragile X syndrome / Phase X $LRMR (September 2025) ✔ Nomlabofusp (CTI-1601) / Friedreichs Ataxia / Phase X ✔ = Expected big stock move confirmed by"
@BiopharmIQ Avatar @BiopharmIQ on X 2025-07-15 23:06:20 UTC 25.9K followers, 9405 engagements

"Let's see how many of the XX biopharma-focused hedge funds hold these tickers (5 is 🔥). $MLTX 7/34 🔥 $LRMR 4/34 $IFRX 1/34 Access our FREE hedge fund screener & search your fav tickers 👇"
@BiopharmIQ Avatar @BiopharmIQ on X 2025-07-20 20:51:43 UTC 25.9K followers, XXX engagements

"Try BPIQ API Free 🎁 Get catalyst & pipeline data integrate seamlessly craft custom spreadsheets. 🔑 Premium API access unlocks 🚀 full platform access 🚀 updated catalysts/pipeline data 🚀 & historical data for robust testing Explore now 👇"
@BiopharmIQ Avatar @BiopharmIQ on X 2025-07-28 15:59:48 UTC 25.9K followers, XXX engagements

"Biotech Stock Catalyst Watchlist 🚀 🎯 Ph2 & Ph3 readouts in Q4 2024 (1/4). $IMMP Phase X $AVIR Phase X $ABUS Phase 2a $ABUS Phase 2a $BRNS Phase 2b $VIR Phase X $DRRX Phase 2b $PLRX Phase 2a $AKRO Phase 2b $CRDL Phase X $ALGS Phase 2a $SYRS Phase X $IKT Phase X $ANAB Phase 2b $BMEA Phase 2b $GALT Phase 2b/3 $BMEA Phase X $MRUS Phase X $KROS Phase X $ADCT Phase X $AFMD Phase X $COGT Phase X $HCM Phase X $ADCT Phase X $SLS Phase 2a $AGIO Phase X $KROS Phase X $COGT Phase X $GLYC Phase X $LLY Phase X $ACLX Phase X $CLRB Phase X $LLY Phase X $BCTX Phase X $JAGX Phase X Check out the image for"
@BiopharmIQ Avatar @BiopharmIQ on X 2024-11-10 20:15:26 UTC 25.9K followers, 17.3K engagements

"📣 Biotech Stock News 07/17 @ Open $SRPT XX% Strategic Restructuring & Pipeline Update $RCKT XX% Receives RMAT Designation for Gene Therapy $MBRX XX% Explores Accelerated Strategic Partnerships $DMAC X% Positive Interim Phase X Results $MAIA X% Peer-Reviewed Pub. on Anticancer Prodrugs $AGEN X% FDA Approves SHINGRIX Prefilled Syringe $XXII X% Launch Confirms Viability of Nicotine Mandate $DNA X% Launches ADME Profiling Service $SDGR X% Expand Research Collaboration on JAK Target $PRAX X% FDA Breakthrough Therapy for Relutrigine $CYBN X% UK Approval for EMBRACE Study $NKGN X% New Funding for"
@BiopharmIQ Avatar @BiopharmIQ on X 2025-07-17 15:39:41 UTC 25.9K followers, 9799 engagements

"🚨 $REPL receives CRL for RP1 BLA in Advanced Melanoma ❌ FDA says IGNYTE trial not adequate & well-controlled & lacks substantial evidence of effectiveness. Issues cited: ⚠ patient heterogeneity ⚠ & confirmatory trial design flaws (e.g. contribution of components). ✅ No safety concerns raised. 📅 Replimune will request Type A meeting with FDA within XX days to explore next steps. See image for companys press release 👇"
@BiopharmIQ Avatar @BiopharmIQ on X 2025-07-22 14:44:16 UTC 25.9K followers, 8240 engagements

"1/ 🚨 PDUFA Pulse: 🔍 Whats on the FDA Radar This July 👀 $REGN: Lynozyfic Approved ✅ $RHHBY: Columvi + GemOx $REPL: RP1 + Opdivo (nivolumab) $GSK: Blenrep combinations (BVd & BPd) $ASND: TransCon hGH $APLS: EMPAVELI (pegcetacoplan) $PTCT: Sephience (sepiapterin) $REGN: Odronextamab $KALV: Sebetralstat Check out the July PDUFA calendar. 📅👇 💡 Cantor initiates coverage on $REPL ahead of July XX PDUFA full context below from @Quantumup1"
@BiopharmIQ Avatar @BiopharmIQ on X 2025-07-02 19:55:37 UTC 25.9K followers, 23K engagements

"📣 Biotech Stock News 07/24 @ Midday $TELO XX% Restores Mitochondrial Health in Cells $IDYA X% Oral Presentation at ESMO 2025 $ATRA X% FDA Acceptance and Priority Review for Tabelecleucel $ANNX X% Completion of Enrollment in ARCHER II Trial $UNCY X% Publication of Oxylanthanum Carbonate Trial Data $ABVX X% Pricing of $650M Public Offering $RHHBY X% Showcases science-driven leadership and innovation $VSTM X% Fast Track Designation for VS-7375 $MNOV X% Enrollment Update for ALS Trials $CADL X% EMA Orphan Designation for CAN-2409 $LLY X% Expiration of Tender Offer $ANIX X% New U.S. Patent for"
@BiopharmIQ Avatar @BiopharmIQ on X 2025-07-24 15:56:23 UTC 25.9K followers, 5286 engagements

"📌 Biotech Stock News 7/25 @ Open 🔔 $LYEL XX% $100M Equity Placement $NXTC XX% Anti-Siglec-15 Treatment Data Update $OMER X% Pricing of $22M Offering $GILD X% Lenacapavir +CHMP Opinion $IPSEY X% Cabometyx EU Approval $EXEL X% CABOMETYX EU Approval $PHVS X% Closing of $201.2M Offering $INCY X% Initial Data for Bispecific Antibody $LLY X% Positive opinion for Alzheimers treatment $ELAN X% Approval of Innovative Canine Tx $BNTX X% COVID-19 Vaccine +CHMP Opinion $KRYS X% VYJUVEK Approval for DEB $MRNA X% Positive Opinion for COVID-19 Vaccine $IONS -X% Recommended for approval in EU $BIIB -1%"
@BiopharmIQ Avatar @BiopharmIQ on X 2025-07-25 15:51:31 UTC 25.9K followers, 3944 engagements

"📌 Biotech Stock News 5/5 @ Open 🔔 $IMMP XX% Efti with KEYTRUDA OS Data $LTRN X% IND Clearance for Ph1b/2 Trial $UBX X% 36-Week Results from Ph2b ASPIRE Study $HOWL X% New Preclinical Data for IL-10 Molecule $RZLT X% Breakthrough Therapy Designation for Ersodetug $NBTX X% Full Results From Ph1 Study $MBRX X% Bolsters Annamycin IP Portfolio $ALVO X% FDA Approval of Interchangeability for SELARSDI $NRXP X% Patent Application for NRX-100 $DNTH X% Completes Enrollment of Ph2 Trial $ASND X% Latest Endocrinology Rare Disease Data $JNJ -X% TREMFYA 24-wk data $NVAX -X% Improved Terms for Collab"
@BiopharmIQ Avatar @BiopharmIQ on X 2025-05-05 15:57:01 UTC 25.9K followers, 3968 engagements

"📌 Biotech Stock News 7/14 @ Open $DARE XX% Ovaprene Interim Phase X Results $RANI XX% Bioequivalence of Novel Oral Agonist $EPIX X% Acquired by Xenotherapeutics $AMLX X% New Analyses from Ph2 Trials $CRNX X% New Long-Term Data on Paltusotine $VSTM X% Publication of Ph2 RAMP XXX Results $GILD X% New Data on Lenacapavir for HIV $RYTM X% Data on MC4R Agonists at ENDO 2025 $NBIX X% One-Year Data on CRENESSITY Efficacy $RARE X% Approval Extended for HoFH Treatment $RARE X% CRL for UX111 AAV Gene Therapy $PHGE X% Ph2b Trial for BX004 Initiated $CORT X% NDA for Relacorilant $CELC X% New Patent for"
@BiopharmIQ Avatar @BiopharmIQ on X 2025-07-14 16:27:05 UTC 25.9K followers, 3841 engagements

"📣 Biotech Stock News 07/22 @ Open $CRDL XX% Database Lock for Phase X Trial $CNTB XX% Appoints Industry Veteran to Board $STRO X% Research Collab. to Advance Standards $CGEM X% Acceptance of Abstracts for Zipalertinib $BIIB X% Highlighting Progress in Alzheimer's Disease $EHTH X% Achieves HITRUST i1 Certification $AZN X% Plans $50B investment in America $PCRX X% Strategic Collaboration to Expand Promotion $SRPT X% Voluntary Pause of ELEVIDYS Shipments $NAMS X% Presenting Alzheimer's Biomarker Data $DARE X% Webinar on DARE to PLAY Difference $OCUL X% Participation in Scientific Conferences"
@BiopharmIQ Avatar @BiopharmIQ on X 2025-07-22 15:47:12 UTC 25.9K followers, 4919 engagements